Thanks to SME Instrument Phase 2 Grant, we will expand clinical trials in Hospitals across Europe with the aim of confirming the results obtained in the ongoing clinical trials. These new Hospitals will include:
- Humanitas Research Hospital, Milano, Italy;
- Ospedale Policlinico San Martino, Genova, Italy;
- Hospital Virgen de la Salud, Toledo, Spain;
- Universitätsklinikum Erlangen, Germany.
Clinical trials will be based on the protocol "A multicentric, single arm, prospective, stratified clinical investigation to evaluate the ability of MammoWave in breast lesions detection", which has been finalized in collaboration with MTA - Medical Trials Analysis (https://www.mtagroup.net/).